BNSF Railway Company v. The Center for Asbestos Related Disease, Inc.

CourtDistrict Court, D. Montana
DecidedMay 6, 2022
Docket9:19-cv-00040
StatusUnknown

This text of BNSF Railway Company v. The Center for Asbestos Related Disease, Inc. (BNSF Railway Company v. The Center for Asbestos Related Disease, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Montana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
BNSF Railway Company v. The Center for Asbestos Related Disease, Inc., (D. Mont. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MONTANA MISSOULA DIVISION

BNSF RAILWAY COMPANY, CV 19–40–M–DLC on behalf of THE UNITED STATES OF AMERICA,

Plaintiff, ORDER

vs.

THE CENTER FOR ASBESTOS RELATED DISEASE, INC.,

Defendant.

A non-party to this case, McGarvey Law, has moved the Court to quash a subpoena duces tecum issued by Plaintiff BNSF Railway Company ex rel. the United States of America (“BNSF”), pursuant to Rule 45 of the Federal Rules of Civil Procedure. (Doc. 51.) Both BNSF and Defendant the Center for Asbestos Related Disease, Inc. (“CARD”) have submitted responsive filings. (Docs. 53; 54.) For the reasons stated herein, the motion will be granted, and the subpoena quashed. The Court will also impose sanctions. BACKGROUND This is a qui tam action brought by BNSF on behalf of the United States. (See generally Doc. 22.) The crux of this action complains that CARD has fraudulently diagnosed patients with asbestos related disease to obtain federal medical benefits. (Id.) CARD is a non-profit entity dedicated to the identification and treatment of asbestos related disease in Lincoln County, Montana. Over the years, thousands of Lincoln County residents have brought lawsuits over their

exposure to asbestos. Many of these lawsuits have been brought against BNSF and many of these plaintiffs have been represented by McGarvey Law. Indeed, McGarvey Law is actively representing plaintiffs in asbestos related

lawsuits against BNSF. BNSF appears to theorize that McGarvey Law is involved in CARD’s ostensible fraudulent scheme. The heart of this theory is that McGarvey Law and CARD “worked in concert to broaden the diagnostic criteria for what qualifies as an asbestos related disease, and knowingly circumvented the

requirements under the Affordable Care Act in order to obtain Medicare benefits for CARD patients and McGarvey clients.” (Doc. 53 at 3.) Because of this, on the afternoon of Friday, December 10, 2021, BNSF sent a Rule 45 non-party subpoena

duces tecum (Doc. 51-1) to McGarvey Law’s general firm email address, firm@mcgarveylaw.com. (Doc. 51-2 at 1.) McGarvey Law did not see the email until Monday, December 13, 2021. (Id.) The subpoena seeks, in relevant part, any documents from January 1, 2010

to December 10, 2021, “sent by [McGarvey Law], or received from, CARD Inc., the CARD Clinic, the CARD Foundation the CARD Board of Directors or any individual CARD employee, CARD board member or CARD health care provider

(including, but not limited to Dr. Charles Brad Black), related to the following” subjects: 1. Whether Dr. Black or any other CARD Clinic providers have been defined as a “qualified physician” for purposes of reading CT scans or chest x-rays.

2. Diagnostic protocols or procedures for inclusion of CARD Clinic patients for further treatment, study or review at CARD based on an equivocal chest x-ray or CT scan.

3. CARD’s federal grants for the screening, diagnosis or treatment of Asbestos Related Disease.

4. Any referrals of CARD patients to the McGarvey law firm for representation or legal services of any kind.

5. Any referrals of McGarvey law firm clients for medical diagnosis, care or treatment to the CARD Clinic.

6. Any payment for services of any kind by McGarvey Law to Dr. Black or any other CARD Clinic employees.

7. Any payments to the CARD Foundation by any person or entity.

8. Any interpretation or discussion of any language under any provisions found in the Affordable Care Act related to the availability of Social Security, Medicare or any other State or Federal benefits based on the diagnosis of Asbestos Related disease.

9. The current lawsuit styled as BNSF RAILWAY COMPANY, on behalf of THE UNITED STATES OF AMERICA, v. The CENTER FOR ASBESTOS RELATED DISEASE, INC., Civil Action No.: CV-19-40-M-DLC.

(Doc. 51-1 at 12–13.) The subpoena required McGarvey Law to accomplish the document production on or before December 27, 2021. (Id. at 3.) McGarvey Law did not respond to the subpoena, and instead, on December 23, 2021, filed its objections to the subpoena and moved this Court for an order quashing it. (Doc.

51.) McGarvey Law challenges the subpoena on various grounds, arguing it should be quashed because it: (1) demands compliance within a patently

unreasonable amount of time; (2) impermissibly seeks cumulative and duplicative documents it could obtain, and has already obtained, from CARD; (3) imposes an undue burden; and (4) seeks irrelevant information. (Id. at 12–15.) McGarvey Law also requests sanctions. (Id. at 15–18.) BNSF defends the subpoena’s validity

and argues sanctions are unwarranted. (Doc. 53.) ANALYSIS Rule 45 permits parties to subpoena documents from non-parties. See

generally Fed. R. Civ. P. 45. But there are limits. Under the threat of sanctions, a non-party subpoena cannot impose an undue burden or expense. Fed. R. Civ. P. 45(d)(1). It also must “allow a reasonable time to comply” and avoid requiring the “disclosure of privileged or other protected matter.” Fed. R. Civ. P. 45(d)(3)(A)(i),

(iii)–(iv). If a Rule 45 subpoena runs afoul of these limitations it must be modified or quashed. Id. Moreover, even though Rule 45 does not specifically incorporate Rule 26’s

limitations on discovery “it is generally accepted that the scope of discovery allowed under Rule 45 is limited” to the same extent as discovery under Rule 26. Jordan v. Commissioner, Mississippi Dept. of Corrections, 947 F.3d 1322, 1329

(11th Cir. 2020); see also Duong v. Groundhog Enters., Inc., 2020 WL 2041939, *6–7 (C.D. Cal. 2020). This understanding is consistent with the Advisory Committee Notes to Rule 45, which provide “the scope of discovery through a

subpoena is the same as that applicable to Rule 34 and the other discovery rules.” Fed. R. Civ. P. 45, Advisory Committee Notes—1970 Amendment. Rule 26 establishes the scope of discovery, stating “[p]arties may obtain discovery regarding any nonprivileged matter that is relevant to any party’s claim

or defense and proportional to the needs of the case.” Fed. R. Civ. P. 26(b)(1). Discovery may also be limited when the request at issue “is unreasonably cumulative or duplicative, or can be obtained from some other source that is more

convenient, less burdensome, or less expensive.” Fed. R. Civ. P. 26(b)(2)(C)(i). Generally, this Court must apply these standards more stringently with respect to “discovery requests directed to non-parties because nonparty witnesses are powerless to control the scope of litigation and discovery, and should not be forced

to subsidize an unreasonable share of the costs of litigation to which they are not a party.” In re Globalstar Securities Litigation, 2005 WL 8173325, *4 (S.D. Cal. 2005) (citing United States v. C.B.S., 666 F.2d 364, 371–72 (9th Cir. 1982))

(internal alterations omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hickman v. Taylor
329 U.S. 495 (Supreme Court, 1947)
Oppenheimer Fund, Inc. v. Sanders
437 U.S. 340 (Supreme Court, 1978)
Mount Hope Church v. Bash Back!
705 F.3d 418 (Ninth Circuit, 2012)
Stormans Inc v. Mary Selecky
738 F.3d 1178 (Ninth Circuit, 2013)
Richard Jordan v. Georgia Department of Corrections
947 F.3d 1322 (Eleventh Circuit, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
BNSF Railway Company v. The Center for Asbestos Related Disease, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/bnsf-railway-company-v-the-center-for-asbestos-related-disease-inc-mtd-2022.